Evaluation of 188Re- IBA as a novel radiopharmaceutical for bone marrow ablation.

In this study, Ibandronate as a third generation of bisphosphonates was labeled with rhenium-188 radionuclide. Production and quality control of 188Re-IBA radiopharmaceutical was investigated. The radiation absorbed dose of this radiopharmaceutical was evaluated for adult male based on biodistribution data in mice using the RADAR and Sparks and Aydogan methodologies. The 188Re-IBA was produced with more than 96% radiochemical purity. The highest value of %ID/g was related to bone with 7.11% at 12 h post-injection. About 48% of injected activity was cumulated on the surface of bone tissue 48 h post-injection. The imaging studies confirmed the biodistribution pattern. Radiation absorbed doses of red bone marrow and osteogenic cells were estimated to about 0.39 and 0.71 mGy MBq-1, respectively. The maximum administrated activity was obtained 73.1 MBq kg-1 (2.0 mCi kg-1) of body weight. Effective dose was evaluated about 0.09 mSv MBq-1. The results were compared with other clinically used bone pain palliation radiopharmaceuticals. It was concluded that the 188Re-IBA radiopharmaceutical has a great tendency to be absorbed in bone tissue and it can provide sufficient care for bone marrow ablation with low undesired dose to other normal organs.

Improvement of the radiographic method for measurement of effective energy of pulsed X-ray emission from a PF device for different anode's insert materials.

In this paper, effective energy of pulsed X-Ray emitted from a Mather-type plasma focus device in stored energy of 2.5 kJ with six different anode's insert materials was measured using radiographic method with attenuation filters. Since intensity and energy of X-ray beam were considerably changed with changing the insert material, the method was improved by using different filters simultaneously in all the experiments and selection of the best filter in each experiment according to the appropriate criteria. Effective energy of pulsed X-ray beam was measured 16, 28, 50, 51, 34 and 44 keV when aluminum, copper, zinc, tin, tungsten and lead were used as insert materials, and aluminum, copper, silver, silver, copper and lead were used as filters, respectively.

Measurement of the effective energy of pulsed X-rays emitted from a Mather-type plasma focus device.

The current study examined the effective energy of pulsed x-rays emitted from a Mather-type plasma focus device with copper anodes at an energy range of 2-3kJ using x-ray transmission radiography. Aluminum filters of different thicknesses and dental x-ray film were used. When air gas was used at a constant voltage of 21kV at 0.3, 0.6, 0.9 and 1.2 mbar, the effective energy of pulsed the x-ray was 10.9, 10.7, 17.3 and 15.8keV, respectively. At 0.6 mbar of air, as the operating voltage increased to 19, 21 and 23kV, the effective energy of the x-ray radiation was 10.6, 10.7 and 12.4keV, respectively. Comprehensive investigation of the characteristics of x-ray emission from plasma focus devices makes it feasible to use this device as an intensive x-ray generator for medical and industrial purposes. The present study is a part of a program which is planned to realize these applications.